Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714631 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Patches in Elderly Patients With Traumatic Rib Fractures
A Phase 4 study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05714631: Clinical Trial Phase 4 study, sponsored by Medical College of Wisconsin.
NCT05714631 is a Phase 4 study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05714631, a Phase 4 study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Many patients are prescribed lidocaine patches for rib fractures despite mixed evidence to their efficacy. The outcome of this trial offers significant benefit to patient care if it finds benefit of their use or if it does not. Reducing opioid use and increasing functional outcomes in geriatric patient suffering rib fractures can improve quality of life and ability to return to prior levels of function. Limiting the need for opioid prescriptions dispensed in the community, particularly to vulnerable geriatric individuals, is also a key aspect in curbing the opioid epidemic. However, even if no difference is found, it would support stopping the use of lidocaine patches in this population as a waste of money and resources. The novel approach of adding the 3rd arm to assess for placebo effect will also carry clinical value, as a placebo effect that reduces opioid use may in fact be enough to support continued use of the products given their overall low side effect risk profile compared to opioids and other pain control medications.
Primary Outcome
Oral Morphine Equivalents Calculated based on opioids used between enrollment in the study until the time of discharge
Interventions
- OTHER Placebo Patch
- DRUG 4% Lidocaine Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-08-01 |
| Phase | Phase 4 |
Why NCT05714631 stopped before completion
NCT05714631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT05714631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05714631 about?
NCT05714631 is a clinical study titled "Lidocaine Patches in Elderly Patients With Traumatic Rib Fractures". Many patients are prescribed lidocaine patches for rib fractures despite mixed evidence to their efficacy. The outcome of this trial offers significant benefit to patient care if it finds benefit of their use or if it does not. Reducing opioid use and increasing functional outcomes in geriatric pati...
What is the current status of trial NCT05714631?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2023-10-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05714631?
The interventions under investigation include: Placebo Patch (OTHER), 4% Lidocaine Patch (DRUG).
Who is sponsoring clinical trial NCT05714631?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05714631's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI